Gene therapy for PNET

Journal of Neuro-Oncology

Volumn 29, Issue 1, 1996, Pages 113-118

  Raffel, Corey ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenovires; Gene therapy; PNET; Retrovires; Viral vectors

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; NEUROECTODERM TUMOR; NONHUMAN; RETROVIRUS; REVIEW;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE; RETROVIRIDAE; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0029946748     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00165524     Document Type: Review

References (38)

1. Miller AD: Human gene therapy comes of age. Nature 357: 455-460, 1992
2. Anderson WF: Human gene therapy. Science 256: 808-813, 1992
3. Morsy MA, Mitani K, Clemens P, Caskey CT: Progress toward human gene therapy. JAMA 270: 2338-2345, 1993
4. Roemer K, Friedmann T: Concepts and strategies for human gene therapy. Eur J Biochem 208: 211-225, 1992
5. Varmus H: Retroviruses. Science 240: 1427-1435, 1988
6. Cone RD, Mulligan RC: High efficiency gene transfer into mammalian cells: Generation of helper free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA 81: 6349-6353, 1984
7. Miller AD. Garcia JV, von Suhr N. Lynch CM, Wilson C, Eiden MV: Construction and properties of retrovirus packaging cells based on gibbon age leukemia virus. J Virology 65(5): 2220-2224, 1991
8. Hajihosseini M, Iavachev L, Price J: Evidence that retroviruses integrate into post-replication host DNA. Embo 12 (13): 4969-4974, 1993
9. Raot T, Vincent N, Chafey P, Vigne E. Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M: Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361: 647-650, 1993
10. Muro-Cacho CA, Samulski RJ, Kaplan D: Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J Immunother 11: 231-237, 1992
11. Geller AI, Freese A: Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase. Proc Natl Acad Sci USA 87: 1149-1153, 1990
12. Kennedy PGE, Steiner I: The use of herpes simplex virus vectors for gene therapy in neurological diseases. Q J Med 86: 697-702, 1993
13. Geller AI: Herpes viruses: Expression of genes in postmitotic brain cells. Curr Opin Genet Dev 3: 81-85, 1993
14. Freese A, Geller AI, Neve R: HSV-l vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology. Biochem Pharmacol 40: 2189-2199, 1990
15. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252: 854-856, 1991
16. Markert JM, Coen DM, Malick A, Mineta T, Martuza RL: Expanded spectrum of viral therapy in the treatment of nervous system tumors. J Neurosurg 77: 590-594, 1992
17. Markert JM, Malick A, Coen DM, Martuza RL: Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery 32: 597-603, 1993
18. Nabel GJ, Felgner PL: Direct gene transfer for immunotherapy and immunization. Trends Biotechnol 11: 211-214, 1993
19. Ahmad I, Longenecker M, Samuel J, Allen TM: Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 53: 1484-1488, 1993
20. Culver KW, Rarn Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552, 1992
21. Neuwelt EA, Weissleder R, Nilaver G, Kroll RA, Roman-Goldstein S, Szumowski J, Pagel MA, Jones RS, Remsen LG, McCormick CI et al.: Delivery of virys-sized iron oxide particles to rodent CNS neurons. Neurosurg 34(4): 777-784, 1994
22. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91(6): 2076-2080, 1994
23. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88, 1993
24. Short MP, Choi BC, Lee JK, Malick A, Breakefield XO, Martuza RL: Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 27: 427-439, 1990
25. Bi WL, Parysek LM, Warnick R, Stambrook PJ: In vitro evidence that metabolic cooperation is reponsible for the bystander effect observed with HSV tk retroviral gene therapy. Human Gene Therapy 4(6): 725-731, 1993
26. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH: The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 81(2): 256-260, 1994
27. Barba D, Hardin J, Sadelain M, Gage FH: Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91(10): 4348-4352, 1994
28. Tapscott SJ, Miller AD, Olson JM, Berger MS, Groudine M, Spence AM: Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci USA 91(17): 8185-8189, 1994
29. Johnson TR, Trojan J, Rudin SD, Ilan J, Tykocinski ML, Ilan J: Evoking an immune response to glioblastoma cells transfected with episome-based plasmid expressing antisense transcripts to insulin-like growth factor I. In: Levine AJ, Schmidek HH (eds) Molecular Genetics of Nervous System Tumors. New York, Wiley-Liss, 1993, pp 387-400
30. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J, Ilan J: Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 89: 4874-4878, 1992
31. Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML, Ilan J: Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259: 94-97, 1993
32. Ram Z, Walbridge S, Heiss JD, Culver KW, Blaese RM, Oldfield EH: In vivo transfer the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J of Neurosurg 80(3): 535-540, 1994
33. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992
34. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827, 1993
35. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579, 1994
36. Hanania EG, FU S, Roninson I, Zu Z, Gottesman MM, Deisseroth AB: Resistance to taxol chemotherapy produced in mouse marrow cells by safety modified retroviruses containing a human MRD-1 transcription unit. Gene Therapy 2: 279-284, 1995
37. Oldfield EH, Ram Z, Chiang Y, Blaese RM: Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GT1 0108. A phase 1/11 study. Human Gene Therapy 6: 55-85, 1995
38. Lundberg JH, Weissman DE, Beatty PA, Ash RC: Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. J Neuro-Onco 13: 151-155, 1992